MoneyWorks4Me

Supriya Lifescience - Quaterly Results

12 Aug 2022 Evaluate
The sales figure stood at Rs. 1013.55 millions for the June 2022 quarter. The mentioned figure indicates a growth of about 31.73% as compared to Rs. 769.42 millions during the year-ago period.The Total revenue for the quarter ended June 2022 of  Rs. 252.50  millions  grew by 226.27% from Rs. 77.39 millions.The company reported a good operating profit of 336.03 millions compared to 173.92 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1013.55 769.42 31.73 1013.55 769.42 31.73 5300.49 3912.45 35.48
Other Income 23.57 19.39 21.56 23.57 19.39 21.56 75.77 49.77 52.24
PBIDT 336.03 173.92 93.21 336.03 173.92 93.21 2215.62 1781.51 24.37
Interest 5.81 9.74 -40.35 5.81 9.74 -40.35 41.98 40.80 2.89
PBDT 330.22 164.18 101.13 330.22 164.18 101.13 2173.64 1740.71 24.87
Depreciation 28.85 24.77 16.47 28.85 24.77 16.47 101.18 67.61 49.65
PBT 301.37 139.41 116.18 301.37 139.41 116.18 2072.46 1673.10 23.87
TAX 48.87 62.02 -21.20 48.87 62.02 -21.20 554.35 437.16 26.81
Deferred Tax 3.00 45.97 -93.47 3.00 45.97 -93.47 32.46 6.94 367.72
PAT 252.50 77.39 226.27 252.50 77.39 226.27 1518.11 1235.94 22.83
Equity 160.96 146.37 9.97 160.96 146.37 9.97 160.97 146.37 9.97
PBIDTM(%) 33.15 22.60 46.67 33.15 22.60 46.67 41.80 45.53 -8.20
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..